Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Michael Pishvaian, MD, PhD
<< Back to Our Featured Experts
Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCC
Dr. Pishvaian on Implications of Entrectinib Study in Pancreatic Cancer
Dr. Pishvaian on the Future of Entrectinib in Pancreatic Cancer
Dr. Pishvaian on Precision Medicine in GI Cancer
Dr. Pishvaian on Molecular Alteration in Pancreatic Cancer
Dr. Pishvaian Discusses Progress in Pancreatic Cancer
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Joseph Uberti, MD, PhD
Naoto Tada Ueno, MD, PhD, FACP
Katsuhiko Uesaka, MD, PhD
Susanna Ulahannan, MD
Michael Ulm, MD
Joseph M. Unger, MS, PhC
Michael Untch, MD, PhD
Santhosh Upadhyaya, MD
James Urbanic, MD
Saad Z. Usmani, MD
Saad Z. Usmani, MD, FACP
Robert G. Uzzo, MD
Robert G. Uzzo, MD, MBA, FACS
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Trending Now
Olaparib Approved in China for Frontline Maintenance in Ovarian Cancer
Precision Medicine Propels Research Efforts in Breast Cancer
Recent Data Muddle Role of Secondary Surgery in Recurrent Ovarian Cancer
FDA Approves Frontline Atezolizumab Plus Carboplatin/Nab-Paclitaxel for Nonsquamous NSCLC
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe